About Us   Technology   Media   Applications   Clinical Trials   Publications   News & Events   Investors  

Multiple Sclerosis - Double-Blind Placebo Control Safety and Feasibility Study

Charité University, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany

21 March, 2010

Charité University, Berlin, Germany:

 

Contact: Dr. Friedemann Paul; +49 (30) 450 639705, friedemann.paul@charite.de
Principal Investigator: Dr. Friedemann Paul

 

 

 


University Medical Center Hamburg-Eppendorf, Hamburg, Germany:

 

Contact: Dr. Sven Schippling; + (49) 40 42803279, s.schippling@uke.uni-hamburg.de
Principal Investigator: Dr. Sven Schippling

Related Links
Link to clinical trial
Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 3rd floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: info@brainsway.com

Created by Catom.